{"id":372190,"title":"Quality Overall Summary - Chemical Entities Clinical Trial Applications Phase III (QOS-CE (CTA - Phase III) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T16:18:26.648000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/templates/quality-overall-summary-chemical-entities-clinical-trial-applications-phase-3.html","snippet":"Quality Overall Summary - Chemical Entities Clinical Trial Applications Phase III (QOS-CE (CTA - Phase III) This HTML document is not a form. Its purpose is to display the information as found on the form for viewing purposes only. If you wish to submit a form, you must use only…","rawSnapshotUrl":"/api/snapshots/raw/372190","browseUrl":"https://replay.healtharchive.ca/job-6/20260411161826/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/templates/quality-overall-summary-chemical-entities-clinical-trial-applications-phase-3.html#ha_snapshot=372190","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}